National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer
Publication date
2021-06-01
Authors
Langendijk, Johannes A
Hoebers, Frank J P
de Jong, Martin A
Doornaert, Patricia A.H.
Terhaard, Chris H.J.
Steenbakkers, Roel J H M
Hamming-Vrieze, Olga
van de Kamer, Jeroen B
Verbakel, Wilko F A R
Keskin-Cambay, Fatma
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.
Keywords
head and neck cancer, model-based selection, national indication protocol, proton therapy, radiation-induced side effects, Radiation-induced side effects, Model-based selection, National indication protocol, Head and neck cancer, Proton therapy, Atomic and Molecular Physics, and Optics, Radiology Nuclear Medicine and imaging, Journal Article
Citation
Langendijk, J A, Hoebers, F J P, de Jong, M A, Doornaert, P, Terhaard, C H J, Steenbakkers, R J H M, Hamming-Vrieze, O, van de Kamer, J B, Verbakel, W F A R, Keskin-Cambay, F, Reitsma, J B, van der Schaaf, A, Boersma, L J & Schuit, E 2021, 'National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer', International journal of particle therapy, vol. 8, no. 1, pp. 354-365. https://doi.org/10.14338/IJPT-20-00089.1